FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4367599265> ?p ?o ?g. }

• W4367599265 endingPage "625" @default.
• W4367599265 startingPage "625" @default.
• W4367599265 abstract "The Netherlands is one of the few countries that has a long-term history of active screening for familial hypercholesterolemia (FH), enabling health-economic analyses.To investigate cost-effectiveness and the return on investment (ROI) of a nationwide cascade case-finding and preventive treatment program starting with identification of FH in children and treatment, from both a societal and health care perspective.Cascade case-finding and early preventive treatment were modeled to simulate the progression of disease and costs of 10-year-olds suspected of having heterozygous FH over a lifetime. The model consisted of 3 health states: alive without coronary heart disease (CHD), alive with CHD, and deceased. Mendelian randomization analysis was used to quantify the risk of a first CHD event as a function of age and total lifetime exposure to low-density lipoprotein cholesterol. Cost-effectiveness was defined as €20 000 ($21 800) per QALYs (quality-adjusted life-years) gained, using incremental cost-effectiveness ratios (ICERs). All future benefits and costs were discounted annually by 1.5% and 4%, respectively.The study compared 2 strategies: (1) cascade screening and initiation of treatment with statins in children (mean age, 10 years) and (2) no screening, later detection, and treatment.Outcome of interest included cost, detection, and successful treatment of FH in terms of life-years gained and QALYs. The clinical and cost outputs for each model in the 2 scenarios (early detection and treatment and later detection and treatment) were totaled to determine the overall cost-effectiveness and ROI attributed to implementation of the Dutch FH program.In this model constructed to simulate the progression of FH in 1000 hypothetical 10-year-olds, from a health care perspective, the program would gain 2.53 QALYs per person, at an additional cost of €23 365 ($25 468) (both discounted). These equated to an ICER of €9220 ($10 050) per QALY gained. From the societal perspective, the detection and treatment program were cost saving over a lifetime compared with no cascade screening for FH. The ROI for the detection and treatment program for FH in children was €8.37 ($9.12).The findings of this study suggest that the early detection and treatment program for FH in children may offer a good value for investment, being both health and cost saving. The findings and interpretations are conditional on assumptions inherent in the health economic model." @default.
• W4367599265 created "2023-05-02" @default.
• W4367599265 creator A5015459043 @default.
• W4367599265 creator A5017617474 @default.
• W4367599265 creator A5020436935 @default.
• W4367599265 creator A5029217424 @default.
• W4367599265 creator A5030377588 @default.
• W4367599265 creator A5064794945 @default.
• W4367599265 creator A5070816464 @default.
• W4367599265 date "2023-06-01" @default.
• W4367599265 modified "2023-10-11" @default.
• W4367599265 title "Cost-effectiveness and Return on Investment of a Nationwide Case-Finding Program for Familial Hypercholesterolemia in Children in the Netherlands" @default.
• W4367599265 cites W1970484759 @default.
• W4367599265 cites W1975299400 @default.
• W4367599265 cites W2028444728 @default.
• W4367599265 cites W2033796658 @default.
• W4367599265 cites W2051459270 @default.
• W4367599265 cites W2086158253 @default.
• W4367599265 cites W2100770509 @default.
• W4367599265 cites W2104299102 @default.
• W4367599265 cites W2116250461 @default.
• W4367599265 cites W2124402284 @default.
• W4367599265 cites W2138269617 @default.
• W4367599265 cites W2142627469 @default.
• W4367599265 cites W2143818894 @default.
• W4367599265 cites W2152147591 @default.
• W4367599265 cites W2166094461 @default.
• W4367599265 cites W2289675293 @default.
• W4367599265 cites W2580665626 @default.
• W4367599265 cites W2750646243 @default.
• W4367599265 cites W2756164819 @default.
• W4367599265 cites W2806317860 @default.
• W4367599265 cites W2947435062 @default.
• W4367599265 cites W2980876689 @default.
• W4367599265 cites W3024375461 @default.
• W4367599265 cites W3027478661 @default.
• W4367599265 cites W3082719615 @default.
• W4367599265 cites W3089256847 @default.
• W4367599265 cites W3183365126 @default.
• W4367599265 cites W3183857127 @default.
• W4367599265 cites W3198898259 @default.
• W4367599265 cites W4206006624 @default.
• W4367599265 cites W4293104177 @default.
• W4367599265 cites W72392028 @default.
• W4367599265 cites W3195977032 @default.
• W4367599265 doi "https://doi.org/10.1001/jamapediatrics.2023.0763" @default.
• W4367599265 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37126315" @default.
• W4367599265 hasPublicationYear "2023" @default.
• W4367599265 type Work @default.
• W4367599265 citedByCount "6" @default.
• W4367599265 countsByYear W43675992652023 @default.
• W4367599265 crossrefType "journal-article" @default.
• W4367599265 hasAuthorship W4367599265A5015459043 @default.
• W4367599265 hasAuthorship W4367599265A5017617474 @default.
• W4367599265 hasAuthorship W4367599265A5020436935 @default.
• W4367599265 hasAuthorship W4367599265A5029217424 @default.
• W4367599265 hasAuthorship W4367599265A5030377588 @default.
• W4367599265 hasAuthorship W4367599265A5064794945 @default.
• W4367599265 hasAuthorship W4367599265A5070816464 @default.
• W4367599265 hasConcept C112930515 @default.
• W4367599265 hasConcept C126322002 @default.
• W4367599265 hasConcept C127454912 @default.
• W4367599265 hasConcept C187212893 @default.
• W4367599265 hasConcept C18903297 @default.
• W4367599265 hasConcept C2778163477 @default.
• W4367599265 hasConcept C2779120738 @default.
• W4367599265 hasConcept C3019080777 @default.
• W4367599265 hasConcept C64332521 @default.
• W4367599265 hasConcept C71924100 @default.
• W4367599265 hasConcept C86803240 @default.
• W4367599265 hasConceptScore W4367599265C112930515 @default.
• W4367599265 hasConceptScore W4367599265C126322002 @default.
• W4367599265 hasConceptScore W4367599265C127454912 @default.
• W4367599265 hasConceptScore W4367599265C187212893 @default.
• W4367599265 hasConceptScore W4367599265C18903297 @default.
• W4367599265 hasConceptScore W4367599265C2778163477 @default.
• W4367599265 hasConceptScore W4367599265C2779120738 @default.
• W4367599265 hasConceptScore W4367599265C3019080777 @default.
• W4367599265 hasConceptScore W4367599265C64332521 @default.
• W4367599265 hasConceptScore W4367599265C71924100 @default.
• W4367599265 hasConceptScore W4367599265C86803240 @default.
• W4367599265 hasIssue "6" @default.
• W4367599265 hasLocation W43675992651 @default.
• W4367599265 hasLocation W43675992652 @default.
• W4367599265 hasOpenAccess W4367599265 @default.
• W4367599265 hasPrimaryLocation W43675992651 @default.
• W4367599265 hasRelatedWork W1963587614 @default.
• W4367599265 hasRelatedWork W1991263975 @default.
• W4367599265 hasRelatedWork W2005049219 @default.
• W4367599265 hasRelatedWork W2012685878 @default.
• W4367599265 hasRelatedWork W2041145027 @default.
• W4367599265 hasRelatedWork W2096351075 @default.
• W4367599265 hasRelatedWork W2108332504 @default.
• W4367599265 hasRelatedWork W2159627298 @default.
• W4367599265 hasRelatedWork W4306319728 @default.
• W4367599265 hasRelatedWork W4367599265 @default.
• W4367599265 hasVolume "177" @default.
• W4367599265 isParatext "false" @default.

• next